Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K7WW
|
|||
| Former ID |
DNC002543
|
|||
| Drug Name |
Uridine Diphosphate Galactose
|
|||
| Synonyms |
Udp galactose; uridine diphosphate galactose; UDP-D-galactopyranose; Uridine pyrophosphogalactose; Uridinediphosphogalactose; UDP-galactose; Udpgal; Uridine diphosphogalactose; UDP-alpha-D-Galactose; Uridine diphosphategalactose; GALACTOSE-URIDINE-5'-DIPHOSPHATE; 2956-16-3; UDP-Gal; CHEMBL439009; CHEBI:67119; UDP-D-galactose; UDP-alpha-D-galactopyranose; UDP-galactopyranose; Uridine-5'-diphosphate-alpha-D-galactose; Uridinediphosphate galactose; Uridine 5'-diphosphogalactose; GDU; UDPgalactose; Uridine 5'-(alpha-D-galactopyranosy
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H24N2O17P2
|
|||
| Canonical SMILES |
C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O
|
|||
| InChI |
1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8+,9-,10+,11-,12-,13-,14-/m1/s1
|
|||
| InChIKey |
HSCJRCZFDFQWRP-ABVWGUQPSA-N
|
|||
| CAS Number |
CAS 2956-16-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
585432, 820510, 822374, 828118, 841579, 7887809, 8010104, 8163516, 10322886, 11532691, 16017796, 26702315, 29285756, 47169957, 50080759, 57329955, 77612459, 85198044, 85198047, 85856214, 85856216, 90344356, 99455629, 103516228, 104344147, 126523149, 134228784, 134356834, 134356838, 134356849, 134356851, 134419202, 134982455, 135651585, 137255161, 152186850, 152255822, 160645661, 160963343, 164161931, 164161944, 164194277, 223730435, 223730438, 227723596, 252452260, 252452263, 252452268
|
|||
| ChEBI ID |
CHEBI:67119
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | UDP-glucose 4-epimerase (GALE) | Target Info | Inhibitor | [2] |
| BioCyc | D-galactose degradation V (Leloir pathway) | |||
| UDP-N-acetyl-D-galactosamine biosynthesis I | ||||
| UDP-N-acetyl-D-galactosamine biosynthesis II | ||||
| KEGG Pathway | Galactose metabolism | |||
| Amino sugar and nucleotide sugar metabolism | ||||
| Metabolic pathways | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Panther Pathway | Fructose galactose metabolism | |||
| Pathwhiz Pathway | Nucleotide Sugars Metabolism | |||
| Galactose Metabolism | ||||
| WikiPathways | Metabolism of carbohydrates | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1782). | |||
| REF 2 | Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site. J Mol Biol. 2002 Apr 26;318(2):491-502. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.